Disease activity related catecholamine response of lymphocytes from patients with rheumatoid arthritis

Annals of the New York Academy of Sciences

Volumn 876, Issue , 1999, Pages 287-297

  Wahle, Matthias ^a   Krause, A ^b   Ulrichs, T ^a   Jonas, D ^a   Von Wichert, P ^a   Burmester, G R ^b   Baerwald, C G O ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; CATECHOLAMINE; NORADRENALIN; OKT 3; PHYTOHEMAGGLUTININ;

ADULT; AGED; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE; MALE; MONONUCLEAR CELL; RECEPTOR DENSITY; RHEUMATOID ARTHRITIS;

EID: 0032809904     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1999.tb07651.x     Document Type: Conference Paper

References (27)

1. 1. ADER, R. et al. 1990. Interaction between the brain and the immune system. Annu. Rev. Pharmacol.Toxicol. 30: 561-602.
2. 2. ROSZMAN, T. L. & W. H. BROOKS. 1988. Signaling pathways of the neuroendocrine-immune network. Prog. Allergy 43: 140-159.
3. 3. FELTEN, S. Y. et al. 1992. Noradrenergic and peptidergic innervation of lymphoid organs. Chem. Immunol. 52: 25-48.
4. 4. KAMMER, G. M. 1988. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 9: 222-229.
5. 5. BAERWALD, C. et al. 1992. Decreased density of β-adrenergic receptors on peripheral blood mononuclear cells in patients with rheumatoid arthritis. J. Rheumatol. 19: 204-210.
6. 6. KRAUSE, A. et al. 1992. Correlation between density of β2-adrenergic receptors on peripheral blood mononuclear cells and serum levels of soluble interleukin-2 receptors in patients with chronic inflammatory disease. Eur. J. Clin. Invest. 22(Suppl. 1): 47-51.
7. 7. ARNETT, F. C. et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31: 315-324.
8. 8. RITCHIE, D. M. et al. 1968. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q. J. Med. 37: 393-406.
9. 9. FELTEN, D. L. et al. 1987. Noradrenergic sympathetic neural interactions with the immune system: Structure and function. Immunol. Rev. 100: 225-260.
10. 3H]alprenolol binding. J. Clin. Invest. 57: 149-155.
11. 3H]yohimbine binding. Biochem. Biophys. Res. Commun. 121: 1-7.
12. 12. BENSCHOP, R. J. et al. 1996. Catecholamine-induced leukocytosis: Early observations, current research, and future directions. Brain Behav. Immun. 10: 77-91.
13. 13. BAERWALD, C. G. O. & G. S. PANAYI. 1997. Neurohumoral mechanisms in rheumatoid arthritis [editorial]. Scand. J. Rheumatol. 26: 1-3.
14. 14. BAERWALD, C. G. O. et al. 1997. Impaired sympathetic influence on the immune response in patients with rheumatoid arthritis due to lymphocyte subset specific modulation of β2-adrenergic receptors. Br. J. Rheumatol. 36: 1262-1269.
15. 2-adrenergic receptors on peripheral blood mononuclear cells in vitro. Cytokine 7: 273-276.
16. 16. JOKINEN, E. I. et al. 1993. Association of in vitro immune functions with the severity of the disease in rheumatoid arthritis. Br. J. Rheumatol. 32: 550-555.
17. 17. ELLIOTT, L. et al. 1992. Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation by dexamethasone, isoproterenol, or prostaglandin E2 either alone or in combination. Cell. Mol. Neurobiol. 12: 411-427.
18. 18. TAMIR, A. et al. 1996. Inhibition of T lymphocyte activation by cAMP is associated with down-regulation of two parallel mitogen-activated protein kinase pathways, the extracellular signal-related kinase and c-Jun N-terminal kinase. J. Immunol. 157: 1514-1522.
19. 19. HARADA, Y. et al. 1996. Factors affecting the cytokine production of human T cells stimulated by different modes of activation. J. Allergy Clin. Immunol. 98: S161-S173.
20. 20. WERNER, C. et al. 1997. Chronic terbutaline treatment desensitizes beta-adrenergic inhibition of lymphocyte activation in healthy volunteers. J. Auton. Pharmacol. 17: 237-242.
21. 21. STITES, D. P. 1994. Clinical laboratory methods tor detection of cellular immunity. In Basic and Clinical Immunology, 8th edit. D. P. Stites et al., Eds. Appleton & Lange, East Norwalk, CT.
22. 22. PIERI, C. et al. 1992. The response of human lymphocytes to phytohemagglutinin is impaired at different levels during aging. Ann. N.Y. Acad. Sci. 673: 110-119.
23. 2+ concentrations in human lymphocytes. Br. J. Pharmacol. 103: 1288-1294.
24. 24. LUECKEN, L. J. & D. T. LYSLE. 1992. Evidence for the involvement of beta-adrenergic receptors in conditioned immunomodulation. J. Neuroimmunol. 38: 209-219.
25. 25. TVEDE, N. et al. 1994. Evidence that the effect of bicycle exercise on blood mononuclear cell proliferative responses and subsets is mediated by epinephrine. Int. J. Sports Med. 15: 100-104.
26. 26. HADDEN, J. W. et al. 1970. Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell. Immunol. 1: 583-595.
27. 27. HEIJNEN, C. J. et al. 1996. Functional α 1-adrenergic receptors on leukocytes of patients with polyarticular juvenile rheumatoid arthritis. J. Neuroimmunol. 71: 223-226.